Company / Net Debt per Share
Haemonetics Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$18.50
FY2025
5-year range
$5.83 / $18.50
FY2021-FY2025
Trend
+50.8%
vs FY2024
Sector context
#28 of 100
Health Care
What the data says
At $18.50, Haemonetics's net debt per share ranks #73 of 100 in the Health Care sector. Net Debt per Share has increased for 3 consecutive years, from $5.83 in FY2022 to $18.50 in FY2025.
Based on SEC 10-K filings.
18.50 in FY2025 with a 5-year CAGR of +41.3%.
Increased from $9.14 to $18.50 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +46.9%
- 5-Year CAGR
- +41.3%
- 10-Year CAGR
- -
Sector benchmark
#73 of 100 in Health CareTop 72% of 100This company $18.50 Sector average $7.44
▼
+148.7% above sector average
Key checks
Key Insights
- Haemonetics's net debt per share has grown for 3 consecutive years.
- In FY2025, net debt per share increased 50.8% year-over-year.
- Ranks #28 out of 100 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.50 | +50.8% |
| FY2024 | $12.27 | +34.2% |
| FY2023 | $9.14 | +56.6% |
| FY2022 | $5.83 | -39.9% |
| FY2021 | $9.70 | +195.9% |
| FY2020 | $3.28 | +11.0% |
| FY2019 | $2.95 | +227.9% |
| FY2018 | -$2.31 | -166.8% |
| FY2017 | $3.46 | -39.0% |
| FY2016 | $5.68 | +9.5% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026